Money, Partners Available Even As Biotech Values, Outlook Decline
This article was originally published in Scrip
Executive Summary
Although biotech stock values continue to fall, all is not grim: capital is available for companies that spend time building relationships with investors and partners are willing to work with firms who act fast when big pharma shows interest.